Clinically relevant molecular subgroups of prostate cancer bone metastases.

被引：0
|
作者：
Thysell, Elin [1 ]
Ylitalo, Erik Bovinder [1 ]
Jernberg, Emma [1 ]
Crnalic, Sead [2 ]
Widmark, Anders [3 ]
Bergh, Anders [1 ]
Wikstrom, Pernilla [1 ]
机构：
[1] Umea Univ, Dept Med Biosci, Pathol, Umea, Sweden
[2] Umea Univ, Dept Surg & Perioperat Sci, Orthoped, Umea, Sweden
[3] Umea Univ, Dept Radiat Sci, Oncol, Umea, Sweden
来源：
CANCER RESEARCH | 2018年 / 78卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B081
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [1] Opioid use among prostate cancer patients with bone metastases.
    Yaldo, Avin
    Wen, Lonnie Kent
    Ogbonnaya, Augustina
    Valderrama, Adriana
    Kish, Jonathan K.
    Eaddy, Michael
    Kreilick, Charles
    Seal, Brian S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [2] The blood in cancer with bone metastases.
    Ward, GR
    LANCET, 1913, 1 : 676 - 677
  • [3] Bone remodeling in relation to androgen receptor activity in prostate cancer bone metastases.
    Ylitalo, Erik Bovinder
    Nordstrand, Annika
    Thysell, Elin
    Jernberg, Emma
    Crnalic, Sead
    Widmark, Anders
    Bergh, Anders
    Lerner, Ulf H.
    Wikstrom, Pernilla
    CANCER RESEARCH, 2018, 78 (16) : 50 - 50
  • [4] Evaluation of treatment patterns and costs for patients with prostate cancer and bone metastases.
    Valdarrama, Adriana
    Yao, Jianying
    Wen, Lonnie Kent
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [5] Possible contribution of thrombospondin-1 to prostate cancer bone metastases.
    Soo, CCY
    Thomas, R
    Roudier, M
    Vesella, RL
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S566 - S566
  • [6] Development of New Compounds Specifically Targeting Prostate Cancer Bone Metastases.
    Weinstein, B. M.
    Kirschenbaum, A.
    Janout, V.
    Regen, S. L.
    Yao, S.
    Levine, A. C.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [7] Quality of life and pain among prostate cancer patients with bone metastases.
    Kurth, H
    McKiernan, J
    Bentkover, JD
    Thomas, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 439S - 439S
  • [8] The Wnt/neta-catenin pathway is expressed in prostate cancer and in bone metastases.
    Chen, G
    Shukeir, N
    Potti, A
    Sircar, K
    Goltzman, D
    Rabbani, SA
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S114 - S114
  • [9] Identification and validation of clinically relevant molecular alterations in prostate cancer
    Schlomm, T.
    Sueltmann, H.
    Koellermann, J.
    UROLOGE, 2008, 47 (09): : 1193 - 1198
  • [10] Identification and validation of clinically relevant molecular alterations in prostate cancer
    Schlomm, T.
    Sueltmann, H.
    Koellermann, J.
    PATHOLOGE, 2009, 30 (02): : 111 - 116
12345